- Home
- BZUN vs ZTEK Comparison
BZUN vs ZTEK Comparison
Compare BZUN & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BZUN
- ZTEK
- Stock Information
- Founded
- BZUN 2007
- ZTEK 2008
- Country
- BZUN China
- ZTEK Canada
- Employees
- BZUN N/A
- ZTEK N/A
- Industry
- BZUN Catalog/Specialty Distribution
- ZTEK Major Chemicals
- Sector
- BZUN Consumer Discretionary
- ZTEK Industrials
- Exchange
- BZUN Nasdaq
- ZTEK Nasdaq
- Market Cap
- BZUN 143.5M
- ZTEK 116.6M
- IPO Year
- BZUN N/A
- ZTEK N/A
- Fundamental
- Price
- BZUN $3.19
- ZTEK $1.03
- Analyst Decision
- BZUN Strong Buy
- ZTEK
- Analyst Count
- BZUN 3
- ZTEK 0
- Target Price
- BZUN $3.20
- ZTEK N/A
- AVG Volume (30 Days)
- BZUN 927.9K
- ZTEK 42.0K
- Earning Date
- BZUN 11-21-2024
- ZTEK 02-11-2025
- Dividend Yield
- BZUN N/A
- ZTEK N/A
- EPS Growth
- BZUN N/A
- ZTEK N/A
- EPS
- BZUN N/A
- ZTEK N/A
- Revenue
- BZUN $1,312,737,613.00
- ZTEK $29,132.00
- Revenue This Year
- BZUN $7.63
- ZTEK N/A
- Revenue Next Year
- BZUN $5.15
- ZTEK N/A
- P/E Ratio
- BZUN N/A
- ZTEK N/A
- Revenue Growth
- BZUN 7.26
- ZTEK 8.15
- 52 Week Low
- BZUN $1.90
- ZTEK $0.50
- 52 Week High
- BZUN $4.38
- ZTEK $1.59
- Technical
- Relative Strength Index (RSI)
- BZUN 56.59
- ZTEK 47.23
- Support Level
- BZUN $2.65
- ZTEK $1.05
- Resistance Level
- BZUN $3.77
- ZTEK $1.16
- Average True Range (ATR)
- BZUN 0.28
- ZTEK 0.09
- MACD
- BZUN 0.10
- ZTEK -0.02
- Stochastic Oscillator
- BZUN 55.07
- ZTEK 10.71
About BZUN Baozun Inc.
Baozun Inc is an e-commerce service partner that helps brands execute their e-commerce strategies in China by selling their goods directly to customers online or by providing services to assist with their e-commerce operations. Its integrated end-to-end e-commerce service capabilities, omni-channel expertise, and technology-driven solutions. Company have two operating segments namely E-Commerce (including BEC and BZI) and Brand Management (BBM).
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.